National Chronicle
Business/Economy Editor's Picks Health Top News

Probe Initiated Against Baby Cough Syrup Maker Maiden Pharma as 66 Children Lost Lives In Gambia

cough syrup maiden pharma, maiden cough syrup, cough syrup, maiden pharmaceuticals, maiden pharmaceuticals cough syrup, maiden pharma share price, maiden share price, promethazine, maiden pharmaceuticals share, promethazine oral solution, promethazine oral solution maiden pharma, maiden pharmaceuticals share price, maiden pharma cough syrup name, maiden pharma cough syrups, cough syrup by maiden pharma, who, maiden pharmaceuticals ltd, gambia, news, pharma news, maiden pharmaceuticals syrup list, maiden pharmaceuticals cough syrup list, maiden pharmaceutical, maiden pharma baddi, maiden pharmaceuticals products, cough syrup maiden pharma, maiden cough syrup, cough syrup, maiden pharmaceuticals, maiden pharmaceuticals cough syrup, maiden pharma share price, maiden share price, promethazine, maiden pharmaceuticals share, promethazine oral solution, promethazine oral solution maiden pharma, maiden pharmaceuticals share price, maiden pharma cough syrup name, maiden pharma cough syrups, cough syrup by maiden pharma, pharma news, maiden pharmaceuticals cough syrup list, maiden pharma baddi, maiden pharmaceuticals products, maiden pharmaceuticals ltd cough syrup, meden pharma pvt. ltd, kofexmalin baby cough syrup, Pharmaceutical industry, Syrup, Cough, Cold medicine, Stock, Share price, Share, Pharmaceutical drug, Promethazine, Oral administration, Solution, The Gambia, Infant, Company, Product, Common cold, World Health Organization, Baddi, Sun Pharmaceutical Industries Ltd., Cough Syrup, Medan, Maghreb, Ban, Drug, Pharmaceutical industry, Syrup, Cough, Cold medicine, Share, Pharmaceutical drug, Promethazine, Oral administration Infant, Company, Product, Common cold, World Health Organization, Baddi, Sun Pharmaceutical Industries Ltd., Maghreb, Ban, Drug,

The government has launched a probe against baby cough syrup maker pharmaceutical company Maiden Pharmaceutical Limited after the World Health Organization issued an alert following the death of 66 infants in The Gambia — a West African country. The WHO warned that the company could be linked to the deaths.

The four baby cough syrups that the company manufactures are — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to the reports, the WHO alerted Drugs Controller General of India (DCGI) about the cough syrups a week ago on September 29. The Central Drugs Standard Control Organisation then immediately took up the matter with the Haryana regulatory authority and launched an investigation.

M/s Maiden Pharmaceutical Limited is located in Haryana’s Sonepat district. According to the reports, it seems that the manufacturer had exported these products only to The Gambia. The company, however, has not made any comment on this matter so far. Maiden Pharma’s administrative office in Delhi’s Pitampura was found shut on Thursday morning.

The WHO has also warned that the medicine may have been distributed outside The Gambia and a global exposure is “possible”.

WHO chief Tedros Adhanom Ghebreyesus said yesterday that the four syrups have been potentially linked with acute kidney injuries and 66 deaths among children.

Related posts

UP HJS Recruitment 2021 Notification: Allahabad High Court 98 vacancies of District Judge,know last date here

Team NC

Treason case against Kanhaiya Kumar, Delhi government approved

Team NC

70% Car buyers are unaware of Car subscription services: Survey

Team NC

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More